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We examined whether maternal dietary choline modulates angio-
genesis in fetal brain. Pregnant C57BL/6 mice were fed either a
choline-deficient (CD), control (CT), or choline-supplemented diet
(CS) from days 12 to 17 (E12-17) of pregnancy and then fetal brains
were studied. In CD fetal hippocampus, proliferation of endothelial
cells (EC) was decreased by 32% (p < 0.01 vs. CTor CS) while differ-
entiated EC clusters (expressing factor VIII related antigen (RA)) in-
creased by 25% (p < 0.01 vs. CT or CS). These changes were
associated with >25% decrease in the number of blood vessels
in CD fetal hippocampus (p < 0.01 vs. CT and CS), with no change
in total cross-sectional area of these blood vessels. Expression of
genes for the angiogenic signals derived from both endothelial
and neuronal progenitor cells (NPC) was increased in CD fetal
hippocampus VEGF C (Vegfc), 2.0-fold, p < 0.01 vs. CT and angio-
poietin 2 (Angpt2), 2.1-fold, (p < 0.01 vs. CT)). Similar increased
expression was observed in NPC isolated from E14 fetal mouse
brains and exposed to low (5 μM), CT (70 μM), or high choline
(280 μM) media for 72 h (low choline caused a 9.7-fold increase
in relative gene expression of Vegfc (p < 0.001 vs. CT and high)
and a 3.4-fold increase in expression of Angpt2, (p < 0.05 vs. CT
and high). ANGPT2 protein was increased 42.2% (p < 0.01). Cyto-
sine-phosphate-guanine dinucleotide islands in the proximity of
the promoter areas of Vegfc and Angpt2 were hypomethylated
in low choline NPC compared to CT NPC (p < 0.01). We conclude
that maternal dietary choline intake alters angiogenesis in the
developing fetal hippocampus.
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Choline is an essential nutrient for mammalian cells (1), and itis needed for membrane formation, for methylation, and for
acetylcholine biosynthesis (2). Pregnant women in the United
States do not eat diets delivering the recommended intake of
choline (3). Large amounts of choline are delivered to the fetus
across the placenta (4), resulting in very high tissue choline con-
centrations in the fetus and newborn (5, 6). Maternal choline
deficiency during pregnancy alters neurogenesis in fetal mouse
hippocampus (7, 8), and this effect is likely mediated by altera-
tions in gene-specific DNA methylation within neuronal progeni-
tor cells (NPC) that will form the hippocampus (9, 10). Rodent
dams fed choline-deficient (CD) diets during late pregnancy had
offspring with diminished progenitor cell proliferation and in-
creased apoptosis in fetal hippocampus (11, 12), accelerated
differentiation of NPC (13–15), insensitivity to long-term poten-
tiation (LTP) when they were adult animals (16), and decremen-
ted visuospatial and auditory memory as adults (17–20). In utero
development of the nervous system requires coordination of neu-
rogenesis with angiogenesis to assure that neurons are supplied
with oxygen and that waste products are removed (21–23). There-
fore, maternal dietary choline also might modulate angiogenesis
in fetal brain.
The balance between angiogenesis and neurogenesis is care-
fully modulated by local cues (growth factors, extracelular matrix)
in the mesoderm (21, 24–27). Endothelial cells (EC), derived
from mesodermal cells, generate blood islands early in gestation
(embryonic day 6.5; E6.5) and by E9-10 the primordial vascula-
ture is formed (21, 28). Angiogenesis and vascular maturation are
synergisticly regulated by vascular endothelial growth factors and
their receptors and by angiopoietin (ANGPT)/endothelial recep-
tor tyrosine kinase (Tie-2) signaling (29–31). EC in the perineural
plexus of a ten-day-old mouse embryo express high levels of
VEGF-receptor 1 (VEGF-R1), VEGF-receptor 2 (VEGF-R2),
and tyrosine kinase with immunoglobulin-like and EGF-like do-
mains 1 (TIE-1) and TIE-2, while their ligands are expressed in
the surrounding tissues. This pattern of growth factors stimulates
the invasion of neuroectoderm (21). VEGF synthesis by neurons
and by NPC lining the ventricular zone of the hippocampus
stimulates capillary ingrowth towards this region (22, 32). Also,
binding of VEGF to its receptors activates the antiapoptotic ki-
nase Akt PI3K that inhibits activation of caspase 9 and caspase 3,
thereby increasing endothelial cell survival (23). Finally, VEGF
mediates axonal guidance (23) and neural progenitor cell migra-
tion (33). Upon VEGF-R2 activation, this receptor is phosphory-
lated, activating ras, p38MAPK, and ERK, directly resulting in
increased cell proliferation and migration (23). Vascular matura-
tion and stabilization are required for functional angiogenesis
(34) and this is mediated by ANGPT (35, 36).
We examined whether EC proliferation and differentiation
in fetal hippocampus were affected by maternal dietary choline,
and we determined whether NPC, when exposed to low choline,
expressed angiogenic signals.
Results
Maternal Choline Deficiency DecreasedMaternal Hepatic Phosphocho-
line. Varying dietary choline intake for 5 d in pregnant dams
reduced hepatic concentrations of phosphocholine as expected:
CD, 201 nmol∕g 26 SE (p < 0.05 different from control
(CT)); CT, 464 nmol∕g 51; and choline-supplemented (CS),
648 nmol∕g 74 (n ¼ 10∕group). These findings match our
previously published data on choline metabolites and maternal
choline diet (8).
Choline Deficiency Increased mRNA Expression Encoding Angiogenic
Signaling Molecules in Fetal Brain and in Cultured Neural Progenitor
Cells. As discussed earlier, angiogenesis and vascular maturation
are regulated by VEGF and its receptors as well as by ANGPT
(29–31). Previous studies on gene expression profiling of NPCs
indicated possible alterations in the mRNA levels of angiogenic
related genes when exposed to choline deficiency (37). Progenitor
cells isolated from E14 fetal mouse brains and grown in low cho-
line (5 μM) medium as compared to CT medium (70 μM choline)
had increased gene expression (relative to TATA box binding pro-
tein (Tbp) housekeeping gene) of Vegfc (9.7-fold, p < 0.001) and
angiopoietin 2 (Angpt2) (3.4-fold, p < 0.05 vs. CT) (Fig. 1). The
expression of these two genes also was increased in E17 fetal
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brain from CD as compared to CTand CS dams (Vegfc by 2-fold,
p < 0.01; Angpt2 by 2.1-fold, p < 0.01).
Choline Deficiency Altered the Protein Levels of ANGPT2 and VEGFC.
Wemeasured ANGPT2 protein levels in NPC samples exposed to
low, normal, and high choline levels by ELISA. Choline defi-
ciency increased ANGPT2 protein levels by 42.2% (p < 0.01 vs.
CT) (Fig. S1B). A similar pattern of changes was observed for
VEGFC) (Fig. S1A).
Maternal Choline Deficiency Decreased Endothelial Cell Proliferation
in the Fetal Hippocampus. The proliferation index (ratio of BrdU-
Isolectin cells/total DAPI-isolectin cells) in EC was decreased in
the dentate gyrus of the hippocampus in the CD group relative to
the CT (p < 0.0001) or CS group (p < 0.001). A similar decrease
was observed when the proliferation index in whole hippocampus
was analyzed in CD and compared to CT (p < 0.01) or supple-
mented groups (p < 0.01) (Fig. 2 A, B; Fig. 3). There were no
differences between groups in the surface of the dentate gyrus
or whole hippocampus (inset Fig. 3).
Maternal Choline Deficiency Decreased the Number of Blood Vessels
Formed in the Fetal Hippocampus. We explored the effect of de-
creased EC proliferation on capillary number and cross-sectional
area. The blood vessels were counted per dentate gyrus and per
whole hippocampus. The number of isolectin-labeled blood
vessels in fetal hippocampus was decreased by >25% in CD as
compared to CT or CS (p < 0.01) (Table 1). There were no sig-
nificant changes in the average cross-sectional area of individual
blood vessels or in the combined cross-sectional area of all the
microvessels from one hippocampus.
Though we observed changes in the hippocampus region, there
were no differences observed in the cingulate and midposterior
neocortex (Table S1). We suggest that choline acts by changing
epigenetic marks and that this may occur in progenitor cells only
at a specific period when they are dividing and differentiating.
Neurogenesis and angiogenesis in the cortical areas start before
embryonic day 12, the beginning of our dietary manipulation. The
regional specificity likely reflects these differences.
Maternal Choline Deficiency Increased the Number of Endothelial Cells
Expressing Von Willebrand factor-Factor VIII Complex in the Fetal Hip-
pocampus. As they differentiate, endothelial cell clusters synthe-
size Von Willebrand (VW) factor and Factor VIII in the Weibel-
Palade bodies within the cells (38). The number of EC clusters
expressing VW factor in fetal hippocampus was increased by
25% in the CD group as compared to CT and CS (p < 0.01)
(Fig. 2 C, D, Fig. 4). A similar pattern was observed in the
CA2, CA3 regions and dentate gyrus of the fetal hippocampus.
Fig. 1. Choline deficiency increases expression of Vegfc and Angpt2 in cul-
tured neural progenitor cells and in E17 fetal brain. E14 mouse brain neural
progenitor cells were grown in low choline (5 μM; CD), (70 μM; CT), or
(280 μM; CS) medium for 72 h. Pregnant mice were fed a low, normal, or
supplemented choline diet between days 12 to 17 of gestation and fetal hip-
pocampi were collected at E17 (n ¼ 5 pups from 5 dams∕group). mRNA was
isolated from NPC and whole brain (WB) and expression levels of Vegfc and
Angpt2, relative to Tbp housekeeping gene, were assessedwith qRTPCR using
the 2−ΔΔCT method. n ¼ 5 plates∕group. Data are presented as mean
SE. * ¼p < 0.05; ** ¼p < 0.01 different from CT and CS by REST analysis.
Fig. 2. Immunohistochemistry studies in fetal brain. A and B: Representative
200X fluorescent images of the CORNUS AMMONI region 1 (CA1) of E17 hip-
pocampus. A multiplex immunolabeling was performed for BrdU (golden
staining—ALEXA 555, white arrowhead A), isolectin IB4 (green fluores-
cence—ALEXA 488, red arrowhead A) and DAPI (blue fluorescence when
bound to genomic DNA, white arrowhead B). The proliferation index of
EC was calculated as the ratio between the number of BrdU positive nuclei
colocalized with isolectin (A) and DAPI positive nuclei colocalized with isolec-
tin (B). Small insets are images of the entire hippocampus area captured with
50X magnification (A—isolectin-BrdU and B—DAPI-isolectin). C and D: Factor
VIII RA staining of E17 fetal mouse hippocampus. Representative 200X fluor-
escent images of blood vessels expressing Factor VIII RA in a 5 μm hippocam-
pal sections; image acquisition was performed with a rhodamine filter—
blood cells fluoresce red (ALEXA 546 nm dye; white arrowheads) and nuclei
fluoresce blue (DAPI staining). C shows small blood vessels with different
trajectories and levels of Factor VIII as well as DAPI positive EC nuclei. D
presents a more intense, Factor VIII positive, blood vessel with a bigger
caliber situated in close proximity to the dentate gyrus.
Fig. 3. Maternal choline deficiency decreases endothelial cell proliferation
in E17 fetal hippocampus: Pregnant mice were fed CD, CT, or CS diet between
days 12 to 17 of gestation and fetal brains were collected at E17. At E15,
all dams received an intraperitoneal (i.p.) dose of BrdU. Brain sections were
probedwith isolectin IB4 and anti-BrdU antibodies. The proliferation index of
EC was calculated as the ratio of colabeled BrdU-isolectin positive cells to
DAPI-isolectin positive cells in both hippocampi (or both dentate gyri) of each
brain in six consecutive 5 μm sections. The surface area of whole hippocampus
(H) and dentate gyrus (DG) were measured for each sample and found to be
constant between the treatments (small inset). Data are presented as
mean SE. n ¼ 6 pups from 6 dams∕group. Groups were compared using
one way ANOVA followed by Tukey-Kramer test. ** ¼p < 0.01








Choline Deficiency Altered Methylation of Several CpG (Cytosine-
Phosphate-Guanine Dinucleotide) Islands Downstream of the Tran-
scription Starting Site (TSS) of Vegfc and Angpt2. Cytosine methyla-
tion modulates gene expression (39). We examined the methy-
lation status of the first three CpG islands from Vegfc and Angpt2
because of their close proximity to the TSS for each gene.
Decreased methylated DNA in both Vegfc and Angpt2 was de-
tected (despite low signal compared to the positive CT (Xist))
in the low choline NPC for all islands (p < 0.01 vs. CT) (Fig. 5).
Discussion
We show, using a rodent model, that maternal dietary choline in-
take modulates angiogenesis in fetal brain. Maternal diets low in
choline were associated with diminished proliferation of EC in
fetal hippocampus. We suggest the following hypotheses: Choline
is an important methyl-donor (9) and a diet low in choline in the
pregnant dam results in decreased DNA methylation in fetal
brain within the promoter of two genes that are important reg-
ulators of angiogenesis (Vegfc and Angpt2). Hypomethylation of
genes is usually associated with increased gene expression (9),
and Vegfc and Angpt2 are over expressed in fetal brain. This
change increases VEGFC and ANGPT2 angiogenic signaling,
causing EC to differentiate more rapidly (and to secrete the pro-
teins VW factor and Factor VIII). EC differentiation ends cell
proliferation and this results in decreased numbers of blood
vessels in the hippocampus. Previously published studies esta-
blished that maternal dietary intake of choline during sensitive
periods of neurodevelopment in the fetus altered hippocampal
neurogenesis (8); in our current study, we learned that these ef-
fects are not limited to neuronal cells but extend to endothelial
cells and blood vessel formation in the fetal hippocampus.
As discussed earlier, angiogenesis and vascular maturation are
regulated by VEGF and ANGPT-TIE2. Though CD was asso-
ciated with increased VEGFC, it was paradoxically associated
with decreased, not increased endothelial cell proliferation. This
modification occurred because differentiation of EC was acceler-
ated, and differentiated cells divide less frequently, if at all. We
assessed endothelial cell differentiation using several proteins
(and glycoproteins) that are specifically made by mature endo-
thelial cells. One such protein is von Willebrand factor (vWf)
which is stored in the Weibel-Palade bodies (25). This protein
stabilizes Factor VIII, a protein involved in the clotting cascade
(40). Expression of VW factor is higher in mature EC, and is
minimal in early endothelial progenitor cells (38). This expression
can be influenced by a number of factors including epigenetic
mechanisms (41), hormones (17 β-estradiol) (42), and homocys-
teine (43) (note that choline availability is an important modula-
tor of homocysteine (44)).
Modifications in the proliferation of EC can be associated with
structural differences in the vascular tree that are reflected in
capillary morphometry and number of blood vessels (21). The
number of blood vessels in fetal brain was decreased in CD, but
the total cross-sectional area was not significantly altered. This
modification may be explained by increased levels of VEGFR li-
gands in the CD group, as this signal encourages formation of
wide lumina with thin walls (21, 45). Studies on pupillary mem-
brane capillaries show that increased ANGPT2 in the absence of
VEGF increases EC death. Disruption of VE-cadherin junctions
by ANGPT2 increases the response to VEGF stimulation in EC
as a survival mechanism (46). ANGPT2 potentiates the effects of
VEGF and therefore, the combination of VEGF and ANGPT2
promotes a rapid increase in capillary diameter and remodeling
of basal lamina (46). VEGF also stimulates nitric oxide synthase
(eNOS) in EC (47). Both eNOS and VEGF can promote micro-
vasculature maturation in combination with increased ANGPT2
levels (48). Indeed, alterations in the choline levels induce high
calretinin expression (15), a known marker of differentiation.
VEGFC binds to VEGF-R2 and 3 and enhances lymphangiogen-
esis, angiogenesis, and neurogenesis (49). By activating VEGF-
R2, VEGFC stimulates endothelial cell migration via P38MAPK
and focal adhesion kinase (FAK) (23). It is possible that NPC
lining the periventriculi areas secrete VEGFC and ANGPT2 as
survival factors (46) that also happen to stimulate angiogenesis.
Choline is an essential nutrient and a major source of methyl
groups used to synthesize S-adenosylmethionine. Low choline
levels alter global and gene-specific DNA and histone methyl-
ation (9, 10, 50). Therefore, we suggest that the gene expression
changes in Vegfc and Angpt2 are the result of epigenetic modifi-
cations. We analyzed the gene sequences of Vegfc and Angpt2 and
found several CpG islands downstream from the promoter area
of these genes, but also at the TSS. These CpGs were hypomethy-
lated in the low choline group; epigenetic modifications occurring
near the promoter area, sometimes many kilobases from the TSS
can alter gene expression by modulating the binding of enhan-
cers/insulators to specific loci (51, 52). DNA hypomethylation
decreases the recruitment of methyl binding domain (MBD)
Table 1. Maternal dietary choline deficiency decreases the number of blood vessels in fetal hippocampus
Angiometric analysis CD CT CS
Number of blood vessels per hippocampus 342 ± 19** 473 ± 21 455 ± 26
Combined cross-sectional area (μm2) 29,507 ± 3,638 38,631 ± 3,734 39,193 ± 1,421
Individual microvessel area (μm2) 101 ± 8 106 ± 7 121 ± 9
Pregnant mouse dams were fed a CD, CT, or CS diet from E12 to E17 when angiogenesis in fetal hippocampi was evaluated. Blood
vasculature was fluorescent labeled using isolectin-ALEXA488 conjugated (green fluorescence) as described in Materials and Methods
section. The number, total surface area, and the diameter of microvessels that were isolectin GS-IB4 positive were measured using the
ImageJ Software in both hippocampi of one fetal brain and the average numbers were reported. Six consecutive sections (5 μm) of
medial hippocampal region from each sample (30 μm total) were analyzed. Statistical analysis was performed by ANOVA and Tukey-
Kramer. Data is presented as mean SE, n ¼ 6 pups from 6 different dams∕group, ** ¼p < 0.01 different from CT and CS groups.
Fig. 4. Maternal choline deficiency increases the number of endothelial cells
expressing Factor VIII and Von Willebrand factor in E17 fetal hippocampus.
Pregnant mice were fed CD, CT, or CS diet between days 12 to 17 of gestation
and fetal brains were collected at E17. Consecutive fetal brain sections were
immunolabeled with anti-VW Factor VIII antibodies conjugated with ALEXA
546 nm. Clusters of endothelial cells expressing VW Factor were counted
in E17 hippocampal sections (DG ¼ dentate gyrus; CA1 ¼ cornu ammonis 1;
CA2 ¼ cornu ammonis 2; CA3 ¼ cornu ammonis 3; and Whole H ¼ whole
hippocampus. The surface area of whole hippocampus (H) and dentate gyrus
(DG) were measured for each sample and found to be constant between the
treatments (small inset). Data are presented as mean SE. n ¼ 7 pups from
7 dams∕group. * ¼p < 0.05, ** ¼p < 0.01, as compared to CT and CS groups
by ANOVA with Tukey-Kramer tests.
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families of proteins such as MeCP2. Once bound to methylated
CpG sites, MeCP2 silences transcription of downstream genes by
virtue of its interaction with a histone deacetylase (HDAC)/Sin3
complex (53). This mechanism modifies chromatin and alters
binding of transcription factors (53).
Computational analysis of CpG islands in Vegfc and Angpt2
(Fig. S2) revealed several CpGs located near putative binding
sites for a number of transcription factors (for Vegfc: AP2, Sp1,
PAX4, bHLH, NF-kB, and NRSF; for Angpt2: HMG, bHLH,
ETS1, ARNTand PPAR). Epigenetic modulation of transcription
factor binding at one or all of these sites could alter angiogenesis.
For example, Sp1 and AP2 enhancers increase Vegf expression
during developmental angiogenesis and this is critical for vascu-
lature formation (54, 55). In pathological situations, Vegfc and d
expression can be modulated by NF-Kappa B activation (56).
There is a NRSF binding site located in the third CpG island
of the Vegfc gene; modifications of epigenetic marks at the NRSF
binding site in Calb1 gene in fetal brain were associated with
altered gene expression (50). Similar mechanisms could alter
VEGF signaling. Angpt2 is up-regulated in endothelial cells by
a hypoxia induced factor binding site located in its first intron
and by Ets-1 (57). SOX18 is a member of the Sry-related
HMG box-containing family of transcription factors and is ex-
pressed transiently in endothelial cells during the development
of blood vessels. Mutations resulting in expression of dominant
negative SOX18 severely impair vascular development (58).
DNA bending induced by the HMG domain can facilitate the
formation of higher-order nucleoprotein complexes altering
H3K4 (59) methylation, suggesting that HMG domain proteins
may have an architectural role in assembling such complexes (60).
The aryl hydrocarbon receptor nuclear translocator (ARNT)
serves as the obligate heterodimeric partner for bHLH-PAS
proteins involved in sensing and coordinating transcriptional
responses to hypoxia and developmental pathways (61). Lastly,
PPARs upregulate angiogenic factors in other model systems (62).
The effects of maternal dietary intake of choline on angiogen-
esis in fetal brain could have great importance for humans. Only
14% of pregnant women in the United States consume adequate
amounts of choline in their diets (and less than 5%of 18–30 young
women who are not pregnant consume the recommended intake)
(3). Approximately half of young women have a single nucleotide
polymorphism in the PEMT gene and inefficiently form new
choline moiety and therefore must eat choline or they develop
organ dysfunction (63–65). These women are likely to need more
choline during pregnancy to sustain normal fetal development
(66, 67). In the United States, pregnant women in the lowest
quartile for choline intake have a 4-fold increased risk of having
a baby with a birth defect compared with women in the highest
quartile for choline intake (68, 69). Thus, humans eat marginal
amounts of choline and a large portion of the population has
increased dietary requirement for choline, making the effects
of choline on fetal brain angiogenesis of potential public health
importance.
Materials and Methods
Additional information in SI Text)
Animals. Timed-pregnant C57BL/6 mice were used in all experiments accord-
ing to a protocol described elsewhere (8). At the end of E11 they were
randomly assigned to one of three feeding groups: CD (CD; AIN-76A diet with
no choline), CT, or CS (CS; AIN-76A diet with 4.95 g∕kg choline chloride) and
fed these diets until they were killed on E17. On E15, a single intraperitoneal
injection of 50 mg∕kg body weight 5-bromo-2′-deoxyuridine (BrdU; Sigma-
Aldrich, Inc.) was administered to the pregnant dams.
Fetal Brain Collection. On E17 the fetal brains from two male pups from each
litter were collected using methods we previously published (8, 70). 5 μm
hippocampal sections were cut in coronal orientation. The remaining brains
were frozen in liquid nitrogen and used for gene expression determinations.
Fetal Mouse NPC in Culture. E14 NPC from C57BL/6 mice were obtained from
Lonza and plated according to the manufacturer’s protocol. Small tertiary
neurospheres were generated as previously described (50) and suspended
in custom Neurobasal medium (D700SA, Atlanta Biologicals) containing
5 μM choline chloride (CD), 70 μM choline chloride (CT) or 280 μM choline
chloride (CS) with the ingredients previously described (50).
Immunohistochemistry in Paraffin Embedded Sections. To assess EC prolifera-
tion, a double immunolabeling technique using both BrdU (S-phase marker)
(71) and isolectin IB4 (vasculature marker) (28, 72) was used. Developmental
angiogenesis occurs in waves (73); therefore we evaluated EC proliferation
over a period of 48 h (E15-E17). Similarly, equivalent sections were probed
for VonWillebrand factor (Factor VIII related antigen, VW factor)—Factor VIII
complex. In all cases, 4′, 6-diamidino-2-phenylindole (DAPI, Sigma) 0.1 μg∕mL
for 20 min was used for staining the nuclear DNA (full details provided
in SI Text).
Image Analysis. Fluorescent images were collected with a Nikon FXA micro-
scope (Nikon) equipped with an Optronics TEC-470 CCD Video Camera
System (Optronics Engineering). The number of blood vessels and the aver-
age cross-sectional area of isolectin positive vessels were counted using the
ImageJ Software version 1.37v (http://rsb.info.nih.gov/ij, NIH) with an inte-
grated macro for analyzing particles. The proliferation index of EC was cal-
culated as the ratio of colabeled BrdU-isolectin positive cells to DAPI-isolectin
Fig. 5. Choline deficiency alters the methylation status of CpG islands within Vegfc and Angpt2. E14 NPC were grown in low, control of CS medium as de-
scribed in Fig. legend 1 (n ¼ 4∕group). Enzymatically sheared DNA samples were enriched in methylated cystosine following the MIRA protocol and analyzed
by real time PCR as described in Materials and Methods section. A and C: Diagram (to scale) of Vegfc (80 Kb) and Angpt2 (16 Kb), respectively, containing the
first three CpG islands analyzed and the gene features in close proximity to these CpGs: exons 1 and 2, TSS. B: Methylation (folds to input DNA) of CpG islands
within Vegfc. Inset shows the amplification curves of positive control Xist gene and no amplification for the negative control APC gene detected by real time
PCR; D: Methylation (folds to input DNA) of CpG islands within Angpt2. Values are reported as mean SE. Statistic analysis was perfomed with REST (rest pair
wise reallocation randomisation test). ** ¼p < 0.01.








positive cells in both hippocampi of each brain in six consecutive 5 μm
sections. For analysis of capillary numbers and cross-sectional volume, we
used consecutive sections totaling 30 μmof thickness from the medial-frontal
region of the hippocampus from six fetuses from different dams. To assess
the number of EC clusters that were VW Factor positive, the fluorescent
structures were counted per entire hippocampus as well as for selected
hippocampal regions: CA1 (Cornus Ammoni region 1), CA2, CA3 and DG
(Dentate Gyrus).
Real-Time RT-PCR. RNA was extracted from cultured NPC or from whole brain
samples using the RNeasy Mini Kit (Qiagen) transcribed to cDNA and 2 ng per
PCR was amplified in the second step. TBP mRNA levels do not vary with
choline availability in the central nervous system, as shown in published
microarray studies (37). Primers were designed for Angpt2 and for Vegfc
and synthesized as described in SI Text. The conditions for the amplification
reactions were: 95 °C for 10 min; 40 cycles of 94 °C for 15 sec, 56 °C for 30 sec,
and 72 °C for 50 sec. The relative quantification method (2ΔΔCT) was used to
analyze gene expression changes as described elsewhere (74).
Methylated CpG Island Recovery Assay (MIRA). Genomic DNA was isolated
from NPC samples using Qiagen DNAeasy minicolumns (Qiagen) following
manufacturer’s protocol (75), quantified with a Nanodrop 8000 spectropho-
tometer (Nanodrop) and stored in elution buffer at −80 °C. In preparation for
the enrichment step, 4,000 ng of gDNA from each sample were digested with
MseI restriction enzyme for 2 h at 37 °C followed by heat-inactivation. Input
DNA aliquots were incubated with recombinant His-MBD2b/MBD3L1 protein
complex followed by capture with protein G coated magnetic beads. Vegfc
and Angpt2 genomic sequences were retrieved from the NIH mouse genome
database (http://www.ncbi.nlm.nih.gov/nuccore) including the gene features
(CpG islands and exons/introns locations). For each CpG island several primer
pairs were designed and synthesized, and PCR amplification performed as
described in detail in SI Text.
Maternal Hepatic Phosphocholine. Phosphocholine is the labile storage form
for choline in liver and is an excellent indicator of dietary choline status (76).
It was assayed using liquid chromatography—electrospray ionization—
isotope dilution mass spectrometry as previously described (77).
Statistical Analysis. For gene expression the analysis was performed using the
Relative Expression Software Tool—Multiple Condition Solver REST-MCS ver-
sion 2 (free from the website http://www.gene-quantification.de/rest.html)
which uses a pair wise fixed reallocation randomization test. All statistical
analyses of epitope levels and vascular tree determinations were performed
using JMP software (V 2; SAS Institute, Cary, NPC) with ANOVA and Tukey-
Kramer tests. Data are presented as mean SE.
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